EUVIMEDEUVIMED entdecken
Vergleichsstudie

[18F]AlF-NOTA-PCP2: a novel PET/CT tracer for enhanced PD-L1 heterogeneity imaging and comparative analysis with [18F]AlF-NOTA-WL12 in glioblastoma xenografts

Yong Wang, Yang Zhang, Yunhao Chen, Shijie Wang, Wei Liu, Zhiguo Liu, Man Hu

European Journal of Nuclear Medicine and Molecular Imaging · 2024

DOI: 10.1007/s00259-024-06743-5 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2024. Verfasst von Yong Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Ji…. Hauptthemen laut MEDLINE: Glioblastoma, Positron Emission Tomography Computed Tomography, B7-H1 Antigen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shandong Postdoctoral Innovation Program, the foundation of Natural Science Foundation of Shandong.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaPositron Emission Tomography Computed TomographyB7-H1 AntigenAnimalsMiceHumansCell Line, TumorTissue DistributionRadioactive TracersHeterocyclic Compounds, 1-RingBrain NeoplasmsHeterocyclic CompoundsRadiopharmaceuticals

Stichwörter der Autor:innen

Comparative analysisHeterogeneityPD-L1PET/CT immunoimagingRadiation

Substanzen

B7-H1 AntigenRadioactive Tracers1,4,7-triazacyclononane-N,N',N''-triacetic acidHeterocyclic Compounds, 1-RingHeterocyclic CompoundsRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, China.
  • Department of Radiation Oncology, Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, Shandon…
  • Department of PET/CT Center, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, China. zgliu0704@sina.com.
  • Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, China. human5770@163.com.

Förderung

  • National Natural Science Foundation of China
  • Shandong Postdoctoral Innovation Program
  • the foundation of Natural Science Foundation of Shandong
  • Science Technology Program of Jinan
  • Higher Educational Institutions Youth Innovation Science and Technology Support Program of Shandong Province
  • China Postdoctoral Science Foundation

Zitieren

APA

Wang, Y., Zhang, Y., Chen, Y., Wang, S., Liu, W., Liu, Z., & Hu, M. (2024). [18F]AlF-NOTA-PCP2: a novel PET/CT tracer for enhanced PD-L1 heterogeneity imaging and comparative analysis with [18F]AlF-NOTA-WL12 in glioblastoma xenografts. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-024-06743-5

Vancouver

Wang Y, Zhang Y, Chen Y, Wang S, Liu W, Liu Z, et al. [18F]AlF-NOTA-PCP2: a novel PET/CT tracer for enhanced PD-L1 heterogeneity imaging and comparative analysis with [18F]AlF-NOTA-WL12 in glioblastoma xenografts. European Journal of Nuclear Medicine and Molecular Imaging. 2024. doi:10.1007/s00259-024-06743-5

BibTeX
@article{Wang2024,
  author = {Wang, Yong and Zhang, Yang and Chen, Yunhao and Wang, Shijie and Liu, Wei and Liu, Zhiguo and Hu, Man},
  title = {[18F]AlF-NOTA-PCP2: a novel PET/CT tracer for enhanced PD-L1 heterogeneity imaging and comparative analysis with [18F]AlF-NOTA-WL12 in glioblastoma xenografts},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2024},
  doi = {10.1007/s00259-024-06743-5}
}
Kostenlos starten →